Box of 25 Tests

The Rapid Response® Influenza A & B + COVID-19 Antigen combo Test is a lateral flow immunoassay intended for the qualitative detection and differentiation of nucleoprotein antigens from SARS-CoV-2, Influenza A and/or Influenza B in nasopharyngeal or anterior nasal swab specimens.

• Covid 19 Sensitivity – 93.6%; Specificity – 99.7%,
• Influenza A Sensitivity – 94.3%; Specificity – 99.7%,
• Influenza B Sensitivity – 93.3%; Specificity – 99.7%,
• Results in 15 minutes
• Can be used reliably with or without virus symptoms
• Variant and combination sensitive
• Health Canada authorized